Edition:
India

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

568.00INR
18 Jul 2018
Change (% chg)

Rs0.15 (+0.03%)
Prev Close
Rs567.85
Open
Rs568.00
Day's High
Rs568.00
Day's Low
Rs568.00
Volume
1,478
Avg. Vol
2,262,954
52-wk High
Rs809.45
52-wk Low
Rs527.00

Latest Key Developments (Source: Significant Developments)

Aurobindo Pharma Gets U.S. FDA Approval To Make Azithromycin Tablets 250 Mg And 500 Mg
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Aurobindo Pharma Ltd ::GETS FINAL APPROVAL FROM USFDA TO MANUFACTURE AZITHROMYCIN TABLETS 250 MG AND 500 MG.DRUG INDICATED FOR TREATMENT OF PATIENTS WITH MILD TO MODERATE INFECTIONS .  Full Article

Aurobindo Pharma Gets USFDA Nod For Ibuprofen OTC Capsules
Monday, 2 Jul 2018 

July 2 (Reuters) - Aurobindo Pharma Ltd ::SAYS RECEIVED USFDA APPROVAL FOR IBUPROFEN OTC CAPSULES.CO'S IBUPROFEN CAPSULES ARE GENERIC EQUIVALENT OF PFIZER’S ADVIL LIQUI-GELS CAPSULES; PRODUCT WILL BE LAUNCHED IN SEP 2018.IBUPROFEN IS USED TO RELIEVE PAIN FROM VARIOUS CONDITIONS SUCH AS HEADACHE, DENTAL PAIN, MUSCULAR ACHES.  Full Article

Aurobindo Pharma Gets U.S. FDA Nod For Ertapenem Injection
Tuesday, 26 Jun 2018 

June 26 (Reuters) - Aurobindo Pharma Ltd ::SAYS CO GETS U.S. FDA APPROVAL FOR ERTAPENEM INJECTION.SAYS PRODUCT WILL BE LAUNCHED IN JULY 2018.  Full Article

Aurobindo Pharma Gets U.S. FDA Approval For Fondaparinux Sodium Injection
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - Aurobindo Pharma Ltd ::SAYS GETS U.S. FDA APPROVAL FOR FONDAPARINUX SODIUM INJECTION.  Full Article

Aurobindo Pharma gets U.S. FDA nod for esomeprazole magnesium DR capsules OTC
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Aurobindo Pharma Ltd :Says ‍received final approval from U.S. FDA to manufacture esomeprazole magnesium delayed-release capsules OTC, 20mg​.Says ‍product will be launched immediately​.  Full Article

Aurobindo Pharma gets USFDA approval for drugs used for treatement of HIV-1 infection
Monday, 21 Aug 2017 

Aug 21 (Reuters) - Aurobindo Pharma Ltd :Receives USFDA tentative approval for Dolutegravir, Lamivudine & Tenofovir Disoproxil Fumarate tablets.Drugs used for treatement of HIV-1 infection along as a regimen in adults and pediatric patients weighing over 40 kgs.  Full Article

Aurobindo Pharma gets USFDA tentative approval for Dolutegravir
Thursday, 22 Sep 2016 

Aurobindo Pharma Ltd :Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the PEPFAR market.  Full Article

Aurobindo Pharma receives USFDA approval for Linezolid injection
Monday, 8 Aug 2016 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Linezolid injection . Product is expected to be launched by Q2 FY 2016-17 .  Full Article

BUZZ-Apotex deal to help India's Aurobindo Pharma deepen EU presence - Citi

** Citi says Aurobindo Pharma Ltd's 74 mln euros ($86.6 mln) deal to buy some European businesses of Canadian firm Apotex International Ltd is part of inorganic strategy